Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 2

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data

Total article views   Abstract views HTML views PDF downloads Totals
5,047 Dovepress* 5,047 0+ 1,833 5,047
Totals 5,047 0 1,833 5,047
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar